Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the pharmacokinetics, safety and tolerability of oral semaglutide in subjects with hepatic impairment to assess the impact of liver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• oral semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED